Healthy Clinical Trial
Official title:
Bioavailability of Chlorogenic and Phenolic Acids From Soluble Coffees
Coffee contributes to a large extent to our daily intake of phenolic compounds which have
been associated with potential health benefits. A study by Richelle et al. (2001), using an
LDL oxidation assay, showed that phenolic compounds in coffee possessed antioxidant activity
which varied depending on the coffee bean source and the degree of roasting. Little is known
about the bioavailability of phenolic compounds from coffee at various roasting degrees.
Therefore, further human studies are required in order to demonstrate the absorption, and
bioavailability of metabolites that may also be efficient in vivo.
The main objective of this clinical trial is to investigate the possible difference in the
bioavailability of chlorogenic and phenolic acids from coffee at various roasting levels.
Coffee contributes to a large extent to our daily intake of phenolic compounds which have
been associated with potential health benefits. A study by Richelle et al. (2001), using an
LDL oxidation assay, showed that phenolic compounds in coffee possessed antioxidant activity
which varied depending on the coffee bean source and the degree of roasting. Little is known
about the bioavailability of phenolic compounds from coffee at various roast levels.
Therefore, further human studies are required in order to demonstrate the absorption, and
bioavailability of metabolites that may also be efficient in vivo.
The main objective of this clinical trial is to investigate the possible difference in the
bioavailability of chlorogenic and phenolic acids from coffee at different roast levels.
After medical examination and approval, subjects will be randomly assigned to one of the
four coffee treatments. Each study period correspond to the ingestion of one the treatments
and study periods are separated by a one week washout period. Blood will be taken as a time
course for 24h while urine will be collected for 30h. Investigators are also blinded with
respect to the dose and the treatment given to the subjects.
;
Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |